Company to highlight how new ready-to-use reagent pack sizes can make testing more accessible to every vet practice and laboratory.

Processus launches as the successor to well-established Reprozyme and Reprodis brands.

The Robexera product has been unveiled as the company prepares to show off its range at London Vet Show from tomorrow (15 November).

Resources designed to highlight incidence of disease and provide support.

Boehringer Ingelheim says its once-daily velagliflozin oral solution Senvelgo “ushers in a new era of care that enables diabetic cats and their owners to live normal lives despite this chronic condition”.

Manufacturer of Ketofen says resources designed around the “fab five” foot treatment team of farmers, vets, foot trimmers, mobility scorers and nutritional consultants.

Fluboral, containing flubendazole and combined with the company’s “unique” Solustab formulation, created to control gastrointestinal nematodes in both species.

“Stock challenges” earlier in the year affected enzootic abortion of ewes vaccine Cevac Chlamydia.

Aprylic supports animals with conditions such as idiopathic epilepsy and cognitive dysfunction.

New range of specially formulated wet and dry foods to aid management of both conditions.

UK-based firm secures patent for its DRC lighting system which, the company claims, offers enhanced patient monitoring and recovery, superior hygiene and improvements in operational efficiency.

Zeleris now indicated for treatment of one of major pathogens responsible for disease.

Avishield IB H120 can now be used in all production lines of chickens including broilers, breeding chickens, future layers and adult laying hens, with no impact on egg production.

Company behind Nexgard Spectra launches NexGard Combo, “first isoxazoline designed specifically for cats”, to range – but discontinues fipronil-containing Broadline.

Developers claim the solution can help chicks adapt to life post-hatching by reducing stress and helping them to feel more comfortable.